(Q42814327)

English

Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation

scientific article published on April 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 November 2017

Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation (English)

1 reference

Europe PubMed Central

7 November 2017

1 reference

based on heuristic

inferred from title

author name string

Galang CK

1

1 reference

Europe PubMed Central

7 November 2017

García-Ramírez J

2

1 reference

Europe PubMed Central

7 November 2017

Solski PA

3

1 reference

Europe PubMed Central

7 November 2017

Westwick JK

4

1 reference

Europe PubMed Central

7 November 2017

Der CJ

5

1 reference

Europe PubMed Central

7 November 2017

Neznanov NN

6

1 reference

Europe PubMed Central

7 November 2017

Oshima RG

7

1 reference

Europe PubMed Central

7 November 2017

Hauser CA

8

1 reference

Europe PubMed Central

7 November 2017

language of work or name

0 references

publication date

1 April 1996

1 reference

Europe PubMed Central

7 November 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Journal of Biological Chemistry

1 reference

Europe PubMed Central

7 November 2017

271

1 reference

Europe PubMed Central

7 November 2017

7992-7998

1 reference

Europe PubMed Central

7 November 2017

14

1 reference

Europe PubMed Central

7 November 2017

The neu oncogene encodes an epidermal growth factor receptor-related protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Amplification of a novel v-erbB-related gene in a human mammary carcinoma.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Growth factor signaling by receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Involvement of pp60c-src with two major signaling pathways in human breast cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Accumulation of p21ras.GTP in response to stimulation with epidermal growth factor and oncogene products with tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Aberrant function of the Ras signal transduction pathway in human breast cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Ras-mediated transcription activation: analysis by transient cotransfection assays

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Transformation suppressor activity of a Jun transcription factor lacking its activation domain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Transformation and transactivation suppressor activity of the c-Jun leucine zipper fused to a bacterial repressor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Mitogenic signaling by colony-stimulating factor 1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc overexpression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Dominant inhibitory mutations in the Mg(2+)-binding site of RasH prevent its activation by GTP

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Two distinct Raf domains mediate interaction with Ras

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Biological assays for Ras transformation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Activation of the neu tyrosine kinase induces the fos/jun transcription factor complex, the glucose transporter and ornithine decarboxylase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

The Ets family of transcription factors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

NIH/3T3 cells transformed with the activated erbB-2 oncogene can be phenotypically reverted by a kinase deficient, dominant negative erbB-2 variant

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Signal transduction by the neu/erbB-2 receptor: a potential target for anti-tumor therapy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.7992

21 January 2018

Identifiers

10.1074/JBC.271.14.7992

1 reference

Europe PubMed Central

7 November 2017

1 reference

Europe PubMed Central

7 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42814327&oldid=1971031153"